Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 227 results found. Search for [ Dilip Shanghvi ]

Results 1 to 21 of 227
BusinessToday.In
May 28, 2021
Revenue from operations grew 4 per cent to Rs 8,522.98 crore in the March-ended quarter against Rs 8,184.94 crore a year ago


BusinessToday.In
May 26, 2021
Stocks to watch out for today: SPARC, CAMS, HDFC, Bajaj Electricals, Emami, Newgen Software Technologies, BPCL, Burger King India, Hercules Hoists and more


BusinessToday.In
February 16, 2021
The RBI board in its meeting reviewed the current economic situation, global and domestic challenges, and various areas of operations of the central bank including ways for strengthening of grievance redress mechanism in banks


BusinessToday.In
November 5, 2020
Virtual Global Investor Roundtable Live: Assuring investors in attendance of strong and reliable returns, Prime Minister Narendra Modi said India's growth will have multiplier effect on world's development and welfare


BusinessToday.In
November 5, 2020
Focus of the roundtable, scheduled to start at 6 PM today, will be around India's economic and investment outlook, structural reforms and the government's vision for the path to a $5 trillion economy


BusinessToday.In
October 23, 2020
The central board of Reserve Bank of India (RBI) met on Friday to discuss the current economic scenario, continued global and domestic challenges and various areas of operations of the central bank


Chitranjan Kumar
September 29, 2020
Hurun India Rich list 2020: Mukesh Ambani's total wealth surged by 73 per cent or by Rs 2,77,700 crore to Rs 6,58,400 crore in the last 12 months, propelling him to become the richest individual in Asia and fourth richest person in the world


BusinessToday.In
August 14, 2020
Government receives dividend from RBI: Reserve Bank of India has decided to maintain the contingency risk buffer at 5.5 per cent.


Rupa Burman Roy
July 20, 2020
Sectorally, barring pharma, all other sectors closed in green territory, with IT index ending 2.6% and banking indices closing 1.5% higher


PTI
July 19, 2020
The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others


PTI
July 19, 2020
The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


BusinessToday.In
New Delhi, June 5, 2020
COVID-19 drug: The clinical trial will be conducted across 12 centres in India in 210 patients for 10 days and the results of the clinical trial are expected by October


BusinessToday.In
New Delhi, May 29, 2020
Three clinical trials are undergoing to test Nafamostat in Covid-19 patients; these trials are being led by the University of Tokyo Hospital, Japan; Gyeongsang National University Hospital (South Korea); and a collaborative trial by University Hospital, Italy, University of Zurich, Switzerland and Yokohoma City University, Japan


Chitranjan Kumar
New Delhi, May 27, 2020
For the fourth quarter ended March 31, 2020 (Q4 FY20), Sun Pharma posted a 37 per cent YoY decline in consolidated profit at Rs 399.8 crore due to one-time loss of Rs 260.6 crore


Manu Kaushik
New Delhi, April 22, 2020
The newly-formed Jio Platform houses all of Reliance's digital businesses, such as telecom arm Jio (mobile and broadband), Jio's suite of apps, digital investments (KAI-OS, Haptik), and tech capabilities like big data, AI and IoT


PB Jayakumar
March 22, 2020
The government has announced it will promote common infrastructure facilities in three 'Bulk Drug Parks' with the financial investment of Rs 3,000 crore in the next five years


BusinessToday.In
New Delhi, February 6, 2020
Sun Pharma Q3 results: The drug maker's revenue from operations grew by 5.36 per cent to Rs 8,154.85 crore as compared to Rs 7,740.19 crore in the corresponding quarter


E Kumar Sharma
January 17, 2020
The Indian Pharmaceutical Alliance in its statement released on 15 January said: There was no discussion at all on the alleged bribes being given by pharma companies to doctors as being reported in the media


Nevin John
Mumbai, December 12, 2019
Suzlon Energy debt resolution: The company had defaulted in repayments of Rs 437.50 crore in respect of its term loans and working capital facilities in March 2019, besides failing to make payments to certain overdue creditors


PAGES 1 OF 12  12345